dc.contributor.author
Gallego-Fabrega, Cristina
dc.contributor.author
Cullell, Natalia
dc.contributor.author
Soriano Tárraga, Carolina
dc.contributor.author
Carrera, Caty
dc.contributor.author
Torres-Aguila, Nuria P.
dc.contributor.author
Muiño, Elena
dc.contributor.author
Cárcel-Márquez, Jara
dc.contributor.author
de Moura, Manuel Castro
dc.contributor.author
Fernández-Sanlés, Alba
dc.contributor.author
Esteller, M.
dc.contributor.author
Elosua, Roberto
dc.contributor.author
Jimenez-Conde, Jordi
dc.contributor.author
Roquer González, Jaume
dc.contributor.author
Montaner, Joan
dc.contributor.author
Krupinski, Jerzy
dc.contributor.author
Fernández Cadenas, Israel
dc.contributor.author
Universitat Autònoma de Barcelona
dc.identifier
https://ddd.uab.cat/record/227682
dc.identifier
urn:10.18632/oncotarget.27469
dc.identifier
urn:oai:ddd.uab.cat:227682
dc.identifier
urn:pmid:32206187
dc.identifier
urn:pmcid:PMC7075467
dc.identifier
urn:pmc-uid:7075467
dc.identifier
urn:articleid:19492553v11p905
dc.identifier
urn:oai:pubmedcentral.nih.gov:7075467
dc.identifier
urn:oai:egreta.uab.cat:publications/d7c38148-8ded-4649-97cd-901b40bb3201
dc.description.abstract
Altres ajuts: This study was funded by the INVICTUS network, Generacion, Maestro EPIGENESIS, FEDER-ERDF, and BasicMar Regist projects from the Carlos III Health Institute, the AGAUR, the RecerCaixa 2013 and the European Regional Development Fund (ERDF). EPIGENESIS project (CarlosIII Institute, Marató TV3 and Fundació MútuaTerrassa).
dc.description.abstract
Background and Purpose: Polymorphisms and serum levels of Matrix Metalloproteinases (MMP) and Tissue Inhibitor of Metalloproteinases (TIMP) have been studied with regard to atheromatous plaques and ischemic stroke, while no studies of DNA methylation (DNAm) patterns of MMP or TIMP have been performed to that end. Here, we evaluate DNAm levels of the MMP and TIMP gene families in human carotid plaques and blood samples of atherothrombotic stroke patients. Methods: We profiled the DNAm status of stable and ulcerated atherosclerotic plaques obtained as pair sets from three patients who underwent carotid endarterectomy surgery. We selected 415 CpG sites, mapping into MMPs and TIMPs genes for further study. Secondly, the statistically associated CpG sites were analyzed in blood samples from two separate atherothrombotic stroke cohorts (total sample size = 307), ischemic stroke-cohort 1 (ISC-1): 37 atherothrombotic patients and 6 controls, ischemic stroke-cohort 2 (ISC-2): 80 atherothrombotic patients and 184 controls. DNAm levels from plaque tissue and blood samples were evaluated using a high-density microarray Infinium, HumanMethylation450 BeadChip and Infinium MethylationEPIC BeadChip. Results: Three CpG sites were statistically significantly associated with unstable plaque portions; cg02969624, q -value = 0.035 (TIMP2), and cg04316754, q -value = 0.037 (MMP24) were hypermethylated, while cg24211657 q -value = 0.035 (TIMP2) was hypomethylated. Association of cg04316754 (MMP24) methylation levels with atherothrombotic risk was also observed in blood tissue: ISC-1 p -values = 0.03, ISC-2 p -value = 1.9 × 10 -04. Conclusions: The results suggest different DNAm status of MMP24 between stable and unstable atherothrombotic carotid plaques, and between atherothrombotic stroke and controls in blood samples.
dc.format
application/pdf
dc.relation
Instituto de Salud Carlos III CPII17-00021
dc.relation
Oncotarget ; Vol. 11 (march 2020), p. 905-912
dc.rights
Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
dc.rights
https://creativecommons.org/licenses/by/4.0/
dc.subject
Atherosclerotic plaque
dc.subject
DNA methylation
dc.subject
Matrix metalloproteinases
dc.title
DNA methylation of MMPs and TIMPs in atherothrombosis process in carotid plaques and blood tissues